St. Francis Cancer Center | St. Francis Cancer Center | Merck MK-3475-604
st francis cancer center, cancer center greenville sc, cancer care greenville sc, aya cancer care, aya cancer care greenville sc
1823
clinical-trial-template-default,single,single-clinical-trial,postid-1823,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-3.2,wpb-js-composer js-comp-ver-4.12,vc_responsive

Clinical Trials

Merck MK-3475-604

A Phase III Randomized, Double-Blind, Placebo-controlled Trial of Pembrolizumab (MK- 3475/SCH900475) in Combination with Etoposide/Platinum (Cisplatin or Carboplatin) for the First-line Treatment of Subjects with Extensive Stage Small Cell Lung Cancer (KEYNOTE-604). >Read More

 

« Available Clinical Trials